These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21475304)

  • 1. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
    Vara D; Salazar M; Olea-Herrero N; Guzmán M; Velasco G; Díaz-Laviada I
    Cell Death Differ; 2011 Jul; 18(7):1099-111. PubMed ID: 21475304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
    Salazar M; Carracedo A; Salanueva IJ; Hernández-Tiedra S; Lorente M; Egia A; Vázquez P; Blázquez C; Torres S; García S; Nowak J; Fimia GM; Piacentini M; Cecconi F; Pandolfi PP; González-Feria L; Iovanna JL; Guzmán M; Boya P; Velasco G
    J Clin Invest; 2009 May; 119(5):1359-72. PubMed ID: 19425170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
    Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G
    Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.
    Vara D; Morell C; Rodríguez-Henche N; Diaz-Laviada I
    Cell Death Dis; 2013 May; 4(5):e618. PubMed ID: 23640460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation.
    Yu HC; Lin CS; Tai WT; Liu CY; Shiau CW; Chen KF
    J Biol Chem; 2013 Jun; 288(25):18249-59. PubMed ID: 23677989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.
    Cuconati A; Mills C; Goddard C; Zhang X; Yu W; Guo H; Xu X; Block TM
    PLoS One; 2013; 8(1):e54595. PubMed ID: 23355882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
    Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.
    Palazuelos J; Ortega Z; Díaz-Alonso J; Guzmán M; Galve-Roperh I
    J Biol Chem; 2012 Jan; 287(2):1198-209. PubMed ID: 22102284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
    Zhang J; Wang E; Zhang L; Zhou B
    Cell Biol Int; 2021 Feb; 45(2):305-319. PubMed ID: 33079432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
    Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
    Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma.
    Hu M; Huang H; Zhao R; Li P; Li M; Miao H; Chen N; Chen M
    Oncol Rep; 2014 Feb; 31(2):649-56. PubMed ID: 24297300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.
    Thomas HE; Mercer CA; Carnevalli LS; Park J; Andersen JB; Conner EA; Tanaka K; Matsutani T; Iwanami A; Aronow BJ; Manway L; Maira SM; Thorgeirsson SS; Mischel PS; Thomas G; Kozma SC
    Sci Transl Med; 2012 Jun; 4(139):139ra84. PubMed ID: 22539746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
    PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.